Brexpiprazole
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Brexpiprazole is a novel D2 dopamine partial agonist investigational product currently in clinical trials for the treatment of depression, schizophrenia, and attention deficit hyperactivity disorder (ADHD). | ||
---|---|---|---|
Targets |
|
Catalog Num | A13527 |
---|---|
Formula | C25H27N3O2S |
Molecular Weight | 433.5733 |
CAS Number | 913611-97-9 |
SMILES | C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4 |
Synonyms | OPC 34712, OPC-34712 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 21 mg/mL (48.43 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.06 mL | 115.32 mL | 230.64 mL |
0.5 mM | 4.61 mL | 23.06 mL | 46.13 mL |
1 mM | 2.31 mL | 11.53 mL | 23.06 mL |
5 mM | 0.46 mL | 2.31 mL | 4.61 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2